In this episode, we set out to understand more about the roll-out of 5G technologies, both in the UK and globally. Some experts believe 5G will usher in the Fourth Industrial Revolution-- a movement Forbes says will generate close to 1$ trillion in economic value by 2025.
For consumers, 5G is promising lightning-fast speeds, up to 100 times faster than 4G, incredibly low latency, which could make the dream of driverless cars a reality, and capacity to carry massive numbers of connections simultaneously
For telecoms companies, especially in the EU, 5G presents an opportunity to seriously rally their stock market after what the Financial Times called “a damaging decade-long price war over mobile data during the 4G era.”
The UK government is putting a strong emphasis on 5G. Phillip Hammond, Chancellor of the Exchequer, has said he wants the UK to become a “world leader” in 5G. The government also published a 70-page manifesto on its future 5G strategy and committed to devoting up to £16 million of the budget to running 5G trials.
We would like to thank our wonderful panel of guests: Benjamin Rhatigan, expert on the Industrial Internet of Things; Ian Fishwick, founder of AIM-listed; Anna Tobin, Forbes contributer on European media and technology; and Mark Stansfeld, Chair of the Worcestershire Local Enterprise Partnership, currently overseeing one of Britain’s first official 5G factory rollouts.
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
Arix Bioscience explain why they co-founded Quench Bio and took part in its $50m series A financing round. Shield Therapeutics provides an update outlining their progress during 2019 which included the FDA approval of their lead product, Feraccru®/Accrufer®.
The partners in the enhanced oil recovery project at Trinity Inniss informed investors that it had injected the first tank of CO₂ into well AT5X in the field and will, over time, determine the impact for enhanced production in offset wells to AT5X.
Boris Johnson’s emphatic December election win has triggered a burst of optimism among British businesses and consumers, weakening the case for a Bank of England interest rate cut this week. Although it remains to be seen if the pickup in confidence will translate into a meaningful boost to growth, economists have been heartened by the range of indicators that have perked up over the last month.